Search

everythinglearnresearchcommunity

for

Search:↓

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Women may need different blood pressure guidelines than men for heart disease prevention.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

New understanding and treatments for hair loss are improving, but more research is needed.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

High testosterone increases heart disease risk in women with PCOS.